Acyclovir |
Antiviral |
III |
6 |
I |
(TSRL inc, 2012; Kristl et al., 1996; Sohn
et al., 2008; Lutker et al.,
2011; Tutughamiarso et al, 2012) |
|
Acetylsalicylic Acid |
Analgesic |
IV |
2 |
I |
(TSRL inc, 2012; Klein et al., 1994;
Vishweshwar et al., 2005; Bond et al.,
2011) |
|
Ibuprofen |
Analgesic |
II |
2 |
I |
(TSRL inc, 2012; Shankland et al., 1996; Erk
et al., 2004; Stone et al.,
2009; Derollez et al., 2010) |
|
Acetaminophen |
Analgesic |
IV |
6 |
I |
(TSRL inc, 2012; Haisa et al., 1974; Naumov
et al., 1998; McGregor et al.,
2002; Parkin et al., 2002; Peterson
et al., 2002; Fabbiani et al.,
2004) |
|
Albendazole |
Anthelmintic |
II |
2 |
II |
(TSRL inc, 2012; Pranzo et al., 2010) |
|
Mebendazole |
Anthelmintic |
II |
3 |
A |
(TSRL inc, 2012; Rodriguez-Caabeiro et al.,
1987; Martins et al., 2009; Ferreira
et al., 2010) |
|
Loratadine |
Antiallergic |
II |
2 |
‡ |
(TSRL inc, 2012; Khunt, 2008; Gala, 1999) |
|
Ferrous sulfate |
Antianemic |
† |
3 |
‡ |
(Wehner et al., 1976) |
|
Folic acid |
Antianemic |
IV |
1 |
Dihydrate |
(TSRL inc, 2012; Mastropaolo et al.,1980) |
|
Diazepam |
Antianxiety |
II |
2 |
‡ |
(TSRL inc, 2012; Camerman et al.,1972) |
|
Amiodarone hydrochloride |
Antiarrhythmic |
II |
1 |
‡ |
(Wu et al., 2005; Cody et al.,
1989) |
|
Digoxin |
Antiarrhythmic |
I |
3 |
Amorphous |
(TSRL inc, 2012; Chiou et al., 1979; Go
et al., 1980; Eberhard et al.,
1983) |
|
Verapamil hydrochloride |
Antiarrhythmic, Antihypertensive |
II |
1 |
‡ |
(TSRL inc, 2012; Carpy et al., 1985; Yoshida
et al., 2010) |
|
Amoxicillin |
Antibiotic |
IV |
1 |
Trihydrate |
(TSRL inc, 2012; Boles et al., 1978) |
|
Azithromycin |
Antibiotic |
II or IV |
3 |
Dihydrate |
(TSRL inc, 2012; Blanco M et al., 2005;
Montejo-Bernardo et al., 2009) |
|
Benzylpenicillin |
Antibiotic |
I or III |
1 |
I |
(TSRL inc, 2012; Dexter et al., 1978) |
|
Cephalexin (hydrochloride or sodium salt) |
Antibiotic |
II |
8 |
IV (monohydrate) |
(Otsuka et al., 1983; Stephenson et
al., 1998; Kennedy et al.,
2003; Kasim et al., 2004;
Aguiar et al., 2011) |
|
Ciprofloxacin |
Antibiotic |
III |
3 |
II (hydrate) |
(TSRL inc, 2012; Turel et al., 2003; Fabbiani
et al., 2008; Fabbiani
et al., 2009; Fabbiani et al.,
2011) |
|
Doxycycline |
Antibiotic |
IV |
2 |
‡ |
(TSRL inc, 2012; Legendre et al., 2012) |
|
Erythromycin |
Antibiotic |
IV |
4 |
Dihydrate |
(TSRL inc, 2012; Fukumori et al., 1983;
Stephenson et al., 1997; Miroshnyk et
al., 2006) |
|
Sulfamethoxazole |
Antibiotic |
IV |
4 |
III (hemihydrate) |
(TSRL inc, 2012; Maury et al., 1985; Hartauer
et al., 1992; Takasuka et
al.,2001; Price et al., 2005;
Fioritto et al., 2007) |
|
Sulfasalazine |
Antibiotic |
II |
2 |
‡ |
(TSRL inc, 2012; Bilton et al., 1999;
Filip et al., 2001) |
|
Trimethoprim |
Antibiotic |
IV |
1 |
‡ |
(TSRL inc, 2012; Koetzle et al., 1976) |
|
Carbamazepine |
Anticonvulsant |
II |
6 |
Dihydrate |
(TSRL inc, 2012; Himes et al.,
1981; Rebou et al.,
1981; Lowes et al., 1987; Lisgarten
et al., 1989; Lang et al.,
2002; Grzesiak et al., 2003; Harris
et al., 2005; Gelbrich et al.,
2006; Kogan et al., 2008; Arlin
et al., 2011) |
|
Phenytoin |
Anticonvulsant |
II |
1 |
I |
(TSRL inc, 2012; Nokhodchi et al., 2003) |
|
Phenobarbital |
Anticonvulsant |
IV |
13 |
A |
(TSRL inc, 2012; Otsuka et al., 1993; Platteau
et al., 2005; Zencirci et al.,
2009; Zencirci et al., 2010) |
|
Amitriptyline hydrochloride |
Antidepressant |
I |
1 |
I |
(TSRL inc, 2012; Klein et al., 1994) |
|
Fluoxetine hydrochloride |
Antidepressant |
I |
1 |
I |
(TSRL inc, 2012; Robertson et al., 1988) |
|
Glibenclamide |
Antidiabetic |
II |
1 |
I |
(TSRL inc, 2012; Byrn et al., 1986) |
|
Metformin hydrochloride |
Antidiabetic |
III |
2 |
A |
(TSRL inc, 2012; Childs et al., 2004) |
|
Metoclopramide hydrochloride |
Antiemetic |
II or IV |
3 |
‡ |
(TSRL inc, 2012; Pabón et al., 1996) |
|
Clonazepam |
Antiepileptic |
† |
1 |
I |
(Chananont et al., 1979) |
|
Ketoconazole |
Antifungal |
II |
2 |
I (enantiomer +) |
(Peeters et al., 1979; Peeters et al.,
2004; Wu et al., 2005) |
|
Fluconazole |
Antifungal |
III |
4 |
I |
(TSRL inc, 2012; Alkhamis et al., 2002; Caira
et al., 2004; Chandavarkar, Jindai,
Kulkarni, 2011) |
|
Miconazole Nitrate |
Antifungal |
† |
3 |
‡ |
(Pedersen et al., 1993; Peeters et al.,
2004) |
|
Promethazine hydrochloride |
Antihistamine |
I |
2 |
‡ |
(TSRL inc, 2012; Borodi et al., 2012) |
|
Atenolol |
Antihypertensive |
III |
2 |
I |
(TSRL inc, 2012; Esteves De Castro et al.,
2007) |
|
Captopril |
Antihypertensive |
III |
2 |
I (B) |
(TSRL inc, 2012; Haoming et al., 1985; Fekete,
1997; Zhenhong et al., 2011) |
|
Enalapril maleate |
Antihypertensive |
I |
2 |
II |
(TSRL inc, 2012; Précigoux et al., 1986;
Evjolfsson, 2003; Kiang et al., 2003) |
|
Losartan |
Antihypertensive |
III |
5 |
I |
(TSRL inc, 2012; Campbell et al., 1997;
Dolitzky et al., 2004; Wu et al.,
1993; Fernández et al., 2002; Tessler
et al., 2004) |
|
Methyldopa |
Antihypertensive |
III |
1 |
‡ |
(TSRL inc, 2012; Neuman et al., 1984) |
|
Nifedipine |
Antihypertensive |
II |
3 |
A= I= α |
(TSRL inc, 2012; Uekama et al., 1992; Grooff
et al., 1997; Gunn et al.,
2012) |
|
Propranolol hydrochloride |
Antihypertensive |
I |
3 |
II |
(TSRL inc, 2012; Bartolomei et al., 1999;
Bredikhin et al., 2004) |
|
Simvastatin |
Antilipemic |
II |
3 |
I |
(TSRL inc, 2012; Cejka et al., 2003; Husak
et al., 2010) |
|
Biperiden |
Antiparkinsonian |
I |
1 |
I |
(TSRL inc, 2012; Codding, 1986) |
|
Carbidopa |
Antiparkinsonian |
I |
‡ |
‡ |
(Lindenberg et al., 2004) |
|
Levodopa |
Antiparkinsonian |
I |
2 |
I |
(TSRL inc, 2012; Mostad et al., 1970; Mostad
et al., 1971; Howard et al.,
1995) |
|
Benserazide hydrochloride |
Antiparkinsonian |
† |
‡ |
‡ |
‡ |
|
Metronidazole |
Antiprotozoal |
IV |
1 |
‡ |
(TSRL inc, 2012; Galván-Tejada et al.,
2002) |
|
Chlorpromazine |
Antipsychotic |
II |
2 |
Anhydrous |
(TSRL inc, 2012; McDowel, 1969; Klein et al.,
1986) |
|
Haloperidol |
Antipsychotic |
II |
1 |
I |
(TSRL inc, 2012; Prasanna et al., 2001) |
|
Omeprazole |
Antiulcer |
† |
1 |
‡ |
(Ohishi et al., 1989) |
|
Ranitidine hydrochloride |
Antiulcer |
III |
4 |
II |
(TSRL inc, 2012; Ngooi et al., 1994,
Agatonovic-Kustrin et al., 1999; Hempel
et al., 2000; Chieng et al.,
2006) |
|
Oseltamivir phosphate |
Antiviral |
I or III |
1 |
‡ |
(TSRL inc, 2012; Kang et al., 2012) |
|
Salbutamol sulfate |
Bronchodilator |
I |
3 |
I |
(Lindenberg et al., 2004; Lulla et
al., 2011, Rao et al., 2011;
Palacio et al., 2007) |
|
Allopurinol |
Chronic gout treatment |
IV |
1 |
I |
(TSRL inc, 2012; Prusiner et al., 1972) |
|
Ethinyl estradiol |
Contraceptive |
I |
1 |
Hemihydrate |
(TSRL inc, 2012; Guguta et al., 2008) |
|
Levonorgestrel |
Contraceptive |
I |
2 |
‡ |
(TSRL inc, 2012; Chang, Chen, 2009) |
|
Norethisterone |
Contraceptive |
I |
1 |
‡ |
(Lindenberg et al., 2004; Reisch et
al., 1993; Shikii et al.,
2005) |
|
Furosemide |
Diuretic |
IV |
3 |
I |
(TSRL inc, 2012; Babu et al., 2010) |
|
Hydrochlorothiazide |
Diuretic |
IV |
2 |
‡ |
(TSRL inc, 2012; Leech et al., 2008) |
|
Prednisone |
Glucocorticoid |
I |
1 |
‡ |
(Vogt et al., 2007; Suitchmezian et
al., 2008) |
|
Azathioprine |
Immunosuppressant |
IV |
2 |
‡ |
(TSRL inc, 2012; Cook, Bugg, 1975; Acharya,1984) |
|
Alendronate sodium |
Inhibitor of bone resorption |
III |
13 |
‡ |
(TSRL inc, 2012; Kieczykowski et al.,1990; Vega
et al., 1996; Finkelstein et
al., 2004; Asnani et al.,
2009) |
|
Isosorbide mononitrate |
Vasodilator |
I |
2 |
‡ |
(Fotaki, Vertzoni, 2010; Kanters et al.,
1993) |
|